# Merida Capital Holdings

Merida Capital Holdings is a Private Equity based in Rye, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Rye, United States
- **Region:** North America
- **Address:** Rye, NY, United States
- **Founded:** 2016
- **Assets under management:** $200M (per the firm, December 2024)
- **Website:** www.meridacap.com
- **LinkedIn:** https://www.linkedin.com/company/merida-capital-holdings

## Regulatory record

- **CRD number:** 287784
- **SEC file number:** 801-121790
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/287784

## About

Merida Capital Holdings is a private equity firm targeting fundamental growth drivers in the cannabis industry. Its investment emphasis focuses on cultivation technologies, products and services tied to cannabis as an agricultural product, plant-based medicine, pharmaceutical constituent, and consumer product. The firm seeks to invest in companies that have transitioned from start-up to revenue-generating growth companies and is invested in over 50 companies across five funds and co-investments.

## Sectors

- Cannabis
- AgriTech & FoodTech
- Healthcare Services
- Biotechnology

## People

- Mitch Baruchowitz — Founder

## Questions

### Who runs investment decisions at Merida Capital Holdings?

Founder Mitch Baruchowitz leads the firm. Merida's public materials do not name an additional CIO, investment committee, or other senior investment partners. The firm's thesis and portfolio construction trace back to Baruchowitz's published perspectives on cannabis normalization and infrastructure investing. For allocators, this signals concentrated decision risk alongside deep sector specialization.

### Does Merida invest directly in cannabis cultivation or retail?

No. Merida explicitly targets the infrastructure and services layer — cultivation technologies, processing equipment, pharmaceutical constituents, and ancillary products — not plant-touching businesses. This structural choice limits direct exposure to the highest-regulatory-risk segments of the cannabis industry while capturing growth in the supply chain buildout. The firm's own materials describe this as investing in providers of essential products and services to cannabis businesses.

### What is Merida's typical investment stage?

Merida focuses on companies that have already transitioned from start-up to revenue generation. The firm describes its role as accelerating proven operating models and supercharging commercial pipelines, rather than incubating pre-revenue ventures. This positions Merida in the expansion and growth-stage segment of the cannabis infrastructure market, where business models have shown product-market fit but need capital and operational guidance to scale.

### Which sectors does Merida explicitly avoid?

Merida avoids plant-touching cannabis businesses: direct cultivation, retail dispensaries, and consumer-facing brands that handle the cannabis flower or derivative products. The firm also does not invest outside the cannabis and hemp ecosystem, maintaining a pure-play sector concentration that excludes traditional technology, healthcare, or industrial investments beyond the cannabis supply chain.

## Related profiles

- [Merian Ventures](https://altss.com/profile/merian-ventures)
- [Meriden Group](https://altss.com/profile/meriden-group)

---

Last updated: 2026-08-11T15:07:26.757Z

Canonical page: https://altss.com/profile/merida-capital-holdings

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology